412 related articles for article (PubMed ID: 33799477)
1. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.
Jee A; Sernoskie SC; Uetrecht J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799477
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of idiosyncratic drug-induced liver injury.
Uetrecht J
Adv Pharmacol; 2019; 85():133-163. PubMed ID: 31307585
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Studies of Idiosyncratic DILI: Clinical Implications.
Uetrecht J
Front Pharmacol; 2019; 10():837. PubMed ID: 31402866
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.
Metushi IG; Cai P; Dervovic D; Liu F; Lobach A; Nakagawa T; Uetrecht J
J Immunotoxicol; 2015; 12(3):247-60. PubMed ID: 25046026
[TBL] [Abstract][Full Text] [Related]
5. What have we learned from animal models of idiosyncratic, drug-induced liver injury?
Roth RA; Ganey PE
Expert Opin Drug Metab Toxicol; 2020 Jun; 16(6):475-491. PubMed ID: 32324077
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanisms of idiosyncratic drug-induced liver injury.
Mak A; Uetrecht J
J Clin Transl Res; 2017 Feb; 3(1):145-156. PubMed ID: 30873473
[TBL] [Abstract][Full Text] [Related]
7. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury.
Woodhead JL; Watkins PB; Howell BA; Siler SQ; Shoda LKM
Drug Metab Pharmacokinet; 2017 Feb; 32(1):40-45. PubMed ID: 28129975
[TBL] [Abstract][Full Text] [Related]
8. Liver Injury Caused by Green Tea Extract in PD-1
Cho T; Wang X; Yeung K; Cao Y; Uetrecht J
Chem Res Toxicol; 2021 Mar; 34(3):849-856. PubMed ID: 33617238
[TBL] [Abstract][Full Text] [Related]
9. Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?
Kenna JG; Uetrecht J
Drug Metab Dispos; 2018 Nov; 46(11):1658-1669. PubMed ID: 30021844
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury.
Mak A; Uetrecht J
J Immunotoxicol; 2019 Dec; 16(1):28-33. PubMed ID: 30663942
[TBL] [Abstract][Full Text] [Related]
11. An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
Song B; Aoki S; Liu C; Susukida T; Ito K
Toxicol Sci; 2018 Apr; 162(2):713-723. PubMed ID: 29319822
[TBL] [Abstract][Full Text] [Related]
12. The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4.
Mak A; Uetrecht J
Chem Res Toxicol; 2015 Aug; 28(8):1567-73. PubMed ID: 26154582
[TBL] [Abstract][Full Text] [Related]
13. Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method.
Teschke R; Danan G
Medicines (Basel); 2024 Apr; 11(4):. PubMed ID: 38667507
[TBL] [Abstract][Full Text] [Related]
14. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
Mak A; Kato R; Weston K; Hayes A; Uetrecht J
Toxicol Sci; 2018 Feb; 161(2):412-420. PubMed ID: 29087505
[TBL] [Abstract][Full Text] [Related]
15. The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.
Tailor A; Faulkner L; Naisbitt DJ; Park BK
Hum Exp Toxicol; 2015 Dec; 34(12):1310-7. PubMed ID: 26614821
[TBL] [Abstract][Full Text] [Related]
16. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
17. Role of immune reactions in drug-induced liver injury (DILI).
Ju C; Reilly T
Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
[TBL] [Abstract][Full Text] [Related]
18. Immunization with amodiaquine-modified hepatic proteins prevents amodiaquine-induced liver injury.
Mak A; Uetrecht J
J Immunotoxicol; 2015; 12(4):361-7. PubMed ID: 25425471
[TBL] [Abstract][Full Text] [Related]
19. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.
Dara L; Liu ZX; Kaplowitz N
Liver Int; 2016 Feb; 36(2):158-65. PubMed ID: 26484420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
